Tempus AI, Inc.
TEM • NASDAQ
Tempus AI, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Eric Lefkofsky, with a market cap of $9.3B.
CEOEric Lefkofsky
Next Earnings
Upcoming earnings announcement for Tempus AI, Inc.
Date
Tuesday, May 5, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.29
Revenue Estimate
$345.5M
Earnings History
Past 7 earnings reports for Tempus AI, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | -$0.04Est: -$0.14 | +71.4% | $367.2MEst: $364.8M | +0.7% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.11Est: -$0.25 | +56.0% | $334.2MEst: $328.0M | +1.9% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.22Est: -$0.34 | +35.3% | $314.6MEst: $298.4M | +5.4% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.24Est: -$0.27 | +11.1% | $255.7MEst: $248.1M | +3.1% | 10-Q |
| Feb 24, 2025 | Q4 2024 | -$0.18Est: -$0.15 | -20.0% | $200.7MEst: $202.8M | -1.0% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.25Est: -$0.44 | +43.2% | $180.9MEst: $179.5M | +0.8% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.63Est: -$1.30 | +51.5% | $166.0MEst: $160.8M | +3.2% | 10-Q |